PFIZER INC — Board/Management Information 2007

Sep 27, 2007

8-K 1 pf8k927.htm PFIZER INC. 8-K DATED SEPT. 27, 2007 Pfizer Inc. 8K - Sept. 27, 2007

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): September 27, 2007

PFIZER INC. (Exact name of registrant as specified in its charter)

Delaware	1-3619	13-5315170
(State or other Jurisdiction of incorporation)	(Commission File Number)	(I.R.S. Employer Identification No.)
235 East 42nd Street New York, New York (Address of principal executive offices)		10017 (Zip Code)

Registrant's telephone number, including area code:

(212) 573-2323 (Former Name or Former Address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

| I tem 5.02 |
| --- |
| On September 27, 2007, Pfizer Inc. ("Pfizer") issued a press
release announcing the election of Suzanne Nora Johnson and James M. Kilts
to the Pfizer Board of Directors effective September 27, 2007. Ms. Johnson
will serve as a member of the Audit Committee and Mr. Kilts will serve
as a member of the Compensation Committee. The information contained in
the press release is deemed to be filed under the Securities Exchange
Act of 1934 as Exhibit 99 to this report, and such press release is incorporated
herein by reference. |

Item 9.01 Financial Statements and Exhibits

(d) Exhibits
99	Press release of Pfizer Inc. dated September 27, 2007

SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

By: /s/ Margaret M. Foran Margaret M. Foran
Title: Senior Vice President-Corporate Governance, Associate General Counsel and Corporate Secretary
Dated: September 27, 2007

EXHIBIT INDEX

Exhibit No.	Description
99	Press release of Pfizer Inc. dated September 27, 2007